Search results for " cost" in Articles / App Notes
Article
Outsourcing Trends in Biopharmaceutical Manufacturing
Trend six: Outsourcing’s growing role in cost-containment
Outsourcing is no longer a top priority when facilities are looking to reduce costs. This may largely be due to saturation and limited ret…
Article
Bioprocessing Advances in Vaccine Manufacture
SUS allow flexible manufacture when, and at the scale needed, with substantial reductions in costs and time, including presterilized equipment. In contrast, stainless-steel bioreactor-anchored facilit…
Article
Single-Use Technologies Prove Effective for Viral Vector Process Development
…nation rates as well as enhance the efficiency of a production facility while reducing manufacturing costs (both operational and maintenance).
While there may be some drawbacks to single-use sy…
Article
Commercial Production of Gene Therapies Using Suspension or Adherent Cell Lines
At the same time, the production platform selected to manufacture clinical material must be scalable in order to enable the target capacity to be reached and promote cost-effectiveness. Adherent cell …
Article
Genetic Vaccine Platforms Demonstrate Their Potential
“This decreased level of process and method development results in a substantial reduction in cost, and more importantly during a pandemic, the time from determination of identity and sequence of the …
Article
Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow
As a result, the variety of buffer solutions used across a biopharma manufacturing facility requires flexible, cost-efficient infrastructure and on-time delivery to meet process demand.
At…
Article
Automating the Biomanufacturing Process
Currently, this is done manually, Lebl says, and this has a direct impact on biopharmaceutical labor costs, which account for 40–50% of production costs, compared with 10–15% in other industries. “A l…
Article
Automation Trend in Fill/Finish Reduces Contamination Risk
The rise of costly biologics over the past 20 years, however, has put greater pressure on downstream fill/finish operations to ensure that quality, safety, and cost efficiency are not compromised at t…
Article
CDMOs Driving Emerging Bio/Pharma Success
In short, the presence of a robust CDMO industry probably reduces the cost of making the product by 50-75% and shortens the time to the clinic by half.
Those time and cost savings accrue to the…
Article
Industry Adoption of Single-Use Systems Remains Low
The movement away from the blockbuster drug model to more targeted therapeutics, however, is driving the need for drug manufacturers to avoid costly investments in traditionally large, stainless steel…